IRIS
PARISI, GIUSEPPE FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.523
EU - Europa 694
AS - Asia 659
SA - Sud America 126
AF - Africa 115
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.120
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.491
SG - Singapore 401
IT - Italia 261
IE - Irlanda 191
CN - Cina 177
BR - Brasile 111
CI - Costa d'Avorio 72
DE - Germania 71
UA - Ucraina 48
RU - Federazione Russa 45
CA - Canada 26
KR - Corea 25
SN - Senegal 25
GB - Regno Unito 17
IN - India 16
CZ - Repubblica Ceca 15
NG - Nigeria 14
NL - Olanda 12
FI - Finlandia 8
FR - Francia 8
CH - Svizzera 7
HK - Hong Kong 7
VN - Vietnam 6
IQ - Iraq 5
PE - Perù 5
JP - Giappone 4
MX - Messico 4
AR - Argentina 3
GR - Grecia 3
SE - Svezia 3
TR - Turchia 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
TH - Thailandia 2
BD - Bangladesh 1
DO - Repubblica Dominicana 1
ES - Italia 1
EU - Europa 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
TG - Togo 1
Totale 3.120
Salva come PNG Salva come JPEG
Città #
Santa Clara 457
Singapore 290
Dublin 191
Chandler 179
Chicago 104
Ashburn 76
Abidjan 72
Boardman 68
Civitanova Marche 65
Cambridge 50
Jacksonville 50
Lawrence 50
Andover 38
Hefei 35
Catania 30
Nanjing 28
Bremen 26
Dakar 25
Des Moines 24
Seoul 24
Toronto 18
Saint Petersburg 17
Los Angeles 16
Milan 15
Abuja 14
Wilmington 14
Beijing 13
Brno 13
San Francisco 11
Washington 11
Council Bluffs 9
Nanchang 9
Rome 9
São Paulo 9
Brooklyn 8
Frankfurt am Main 6
Hong Kong 6
Redwood City 6
Shenyang 6
Amsterdam 5
Arequipa 5
Genoa 5
Hebei 5
Munich 5
Palermo 5
San Mateo 5
Tianjin 5
Turku 5
Bernareggio 4
Changsha 4
Dong Ket 4
New York 4
Pune 4
The Dalles 4
Tokyo 4
Turin 4
Baghdad 3
Bari 3
Falls Church 3
Favara 3
Guangzhou 3
Jiaxing 3
Lappeenranta 3
Messina 3
Misterbianco 3
Naples 3
Ottawa 3
Pinhais 3
Reggio Emilia 3
Seattle 3
Altamura 2
Ankara 2
Ansbach 2
Atlanta 2
Baku 2
Bangkok 2
Basel 2
Belo Horizonte 2
Birmingham 2
Brescia 2
Cagliari 2
Chennai 2
Costa di Rovigo 2
Curitiba 2
Duque de Caxias 2
Enna 2
Esslingen am Neckar 2
Gravina di Catania 2
Hanoi 2
Houston 2
Johannesburg 2
London 2
Montreal 2
Moscow 2
Nardò 2
Ningbo 2
Nuremberg 2
Olomouc 2
Paris 2
Porto Alegre 2
Totale 2.271
Salva come PNG Salva come JPEG
Nome #
General anesthesia, conscious sedation, or nothing: Decision-making by children during painful procedures 80
YKL-40 as marker of severe lung disease in cystic fibrosis patients. 73
Serum YKL-40 in children with asthma 70
SAFETY AND EFFICACY OF SUBLINGUAL SPECIFIC IMMUNOTHERAPY TO HOUSE DUST MITE USING A DIFFERENT DOSAGE: A PILOT STUDY. 68
Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review 65
Pilot study shows right ventricular diastolic function impairment in young children with obstructive respiratory disease 64
HMGB1 as a new biomarker of celiac disease in children: a multicenter study 63
Minor pulmonary malformations in a child 62
Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease 62
Lung clearance index: A new measure of late lung complications of cancer therapy in children 62
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review 62
Focus on pleiotropic role of HMGB1 in the onset of allergic and non- allergic respiratory diseases 61
Lactoferrin: Cytokine modulation and application in clinical practice 61
HMGB1 values and response to HBV vaccine in children with celiac disease 60
Exhaled breath temperature in astmatic children 59
Severe Kawasaki disease in a 3-month-old patient: a case report. 59
Hypertransaminasemia in children is not always as simple as it seems 59
Liver disease in Cystic Fibrosis: an update 58
Cetirizine use in childhood: An update of a friendly 30-year drug 57
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre 55
Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool 55
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility 54
Novel therapeutic targets for allergic airway disease in children 54
High mobility Group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate - severe asthma 53
Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature 53
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study 52
Proposal for a new therapeutic high dosage of Pidotimod in children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome: A randomized controlled study 52
Genetic disorders of surfactant deficiency and neonatal lung disease 51
Gastroesophageal reflux and respiratory diseases: Does a real link exist? 51
Antihistamines in children and adolescents: A practical update 51
The Role of Ultrasound in the Diagnosis of Pulmonary Infection Caused by Intracellular, Fungal Pathogens and Mycobacteria: A Systematic Review 50
Severe disease in Cystic Fibrosis and fecal calprotectin levels 50
Biomarkers in pediatric lung diseases including cystic fibrosis 50
Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: A pilot study 50
Cystic Fibrosis: Fighting Together Against Coronavirus Infection 49
Focus on gastroesophageal reflux disease in patients with cystic fibrosis 49
Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients 48
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: A pilot study on short-term efficacy 47
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis 47
Lung clearance index for evaluation of late complications of cancer therapy in children 46
Antihistamines: ABC for the pediatricians 46
The immunomodulatory role of vitamin D in respiratory diseases 45
Monoclonal antibodies in treating food allergy: A new therapeutic horizon 45
Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination 45
Lower airway microbiota 44
Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype 43
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 42
LUNG CLEARANCE INDEX: a new biomarker of ventilation inhomogeneity in pediatric respiratory diseases. 40
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 40
Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children? 39
Long-term effects of bronchopulmonary dysplasia on lung function: a pilot study in preschool children’s cohort 39
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria 38
Type 2 inflammation in cystic fibrosis: New insights 38
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis 37
Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheat 33
Upper and lower airways diseases in childhood 31
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic 25
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease 23
Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study 20
Pidotimod in allergic diseases 20
Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer 19
Protracted bacterial bronchitis: more to know 18
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study 17
Cystic Fibrosis and Oxidative Stress: The Role of CFTR 16
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis 16
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population 16
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series 15
Fungi and non-tuberculous mycobacteria: emerging pathogens in cystic fibrosis 15
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review 14
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial 14
Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: a pilot study 14
Nasal microbiome in chronic rhinosinusitis 13
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease 13
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study 13
Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia 13
Foreign Body Aspiration in Children: Retrospective Case Series and Literature Update 12
Totale 3.243
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.525
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 5 20 12 39 20 18 2 6 15 10 7
2021/2022295 17 42 1 3 43 2 39 10 26 3 7 102
2022/2023656 50 12 36 42 55 109 4 120 160 6 35 27
2023/2024394 15 39 30 25 26 114 3 31 0 1 67 43
2024/20251.581 47 188 68 112 292 296 45 27 73 145 154 134
2025/20261 1 0 0 0 0 0 0 0 0 0 0 0
Totale 3.243